Selected research
Industry Research
Peptide Synthesis CDMO Services Industry Research Report 2026
Market perspective
The global Peptide Synthesis CDMO Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Peptide Synthesis CDMO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Peptide Synthesis CDMO Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Peptide Synthesis CDMO Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Peptide Synthesis CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Peptide Synthesis CDMO Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Peptide Synthesis CDMO Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peptide Synthesis CDMO Services Market by Company
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem
Peptide Synthesis CDMO Services Segment by Type
GMP Services
Non-GMP Services
Peptide Synthesis CDMO Services Segment by Application
Commercial
Scientific Research
Other
Peptide Synthesis CDMO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis CDMO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peptide Synthesis CDMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- GMP Services
- Non-GMP Services
Applications
- Commercial
- Scientific Research
- Other
Companies covered
- Bachem
- CordenPharma
- PolyPeptide
- AmbioPharm
- Genscript
- Thermo Fisher
- USV Peptides
- Bio Basic
- ScinoPharm
- JPT
- CBL
- Piramal Pharma
- CPC Scientific
- Creative Peptides
- Chinese Peptide Company
- ChengDu ShengNuo Biotec
- AppTec Co., Ltd.
- GL Biochem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Peptide Synthesis CDMO Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 GMP Services
- 2.2.3 Non-GMP Services
- 2.3 Peptide Synthesis CDMO Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial
- 2.3.3 Scientific Research
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Peptide Synthesis CDMO Services Breakdown Data by Type
- 3.1 Global Peptide Synthesis CDMO Services Historic Market Size by Type (2021-2026)
- 3.2 Global Peptide Synthesis CDMO Services Forecasted Market Size by Type (2027-2032)
4 Peptide Synthesis CDMO Services Breakdown Data by Application
- 4.1 Global Peptide Synthesis CDMO Services Historic Market Size by Application (2021-2026)
- 4.2 Global Peptide Synthesis CDMO Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Peptide Synthesis CDMO Services Market Perspective (2021-2032)
- 5.2 Global Peptide Synthesis CDMO Services Growth Trends by Region
- 5.2.1 Global Peptide Synthesis CDMO Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Peptide Synthesis CDMO Services Historic Market Size by Region (2021-2026)
- 5.2.3 Peptide Synthesis CDMO Services Forecasted Market Size by Region (2027-2032)
- 5.3 Peptide Synthesis CDMO Services Market Dynamics
- 5.3.1 Peptide Synthesis CDMO Services Industry Trends
- 5.3.2 Peptide Synthesis CDMO Services Market Drivers
- 5.3.3 Peptide Synthesis CDMO Services Market Challenges
- 5.3.4 Peptide Synthesis CDMO Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Peptide Synthesis CDMO Services Players by Revenue
- 6.1.1 Global Top Peptide Synthesis CDMO Services Players by Revenue (2021-2026)
- 6.1.2 Global Peptide Synthesis CDMO Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Peptide Synthesis CDMO Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Peptide Synthesis CDMO Services Head Office and Area Served
- 6.4 Global Peptide Synthesis CDMO Services Players, Product Type & Application
- 6.5 Global Peptide Synthesis CDMO Services Manufacturers Established Date
- 6.6 Global Peptide Synthesis CDMO Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Peptide Synthesis CDMO Services Market Size (2021-2032)
- 7.2 North America Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 7.4 North America Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Peptide Synthesis CDMO Services Market Size (2021-2032)
- 8.2 Europe Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 8.4 Europe Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Peptide Synthesis CDMO Services Market Size (2021-2032)
- 9.2 Asia-Pacific Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Peptide Synthesis CDMO Services Market Size (2021-2032)
- 10.2 South America Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 10.4 South America Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Peptide Synthesis CDMO Services Market Size (2021-2032)
- 11.2 Middle East & Africa Peptide Synthesis CDMO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bachem
- 12.1.1 Bachem Company Information
- 12.1.2 Bachem Business Overview
- 12.1.3 Bachem Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.1.4 Bachem Peptide Synthesis CDMO Services Product Portfolio
- 12.1.5 Bachem Recent Developments
- 12.2 CordenPharma
- 12.2.1 CordenPharma Company Information
- 12.2.2 CordenPharma Business Overview
- 12.2.3 CordenPharma Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.2.4 CordenPharma Peptide Synthesis CDMO Services Product Portfolio
- 12.2.5 CordenPharma Recent Developments
- 12.3 PolyPeptide
- 12.3.1 PolyPeptide Company Information
- 12.3.2 PolyPeptide Business Overview
- 12.3.3 PolyPeptide Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.3.4 PolyPeptide Peptide Synthesis CDMO Services Product Portfolio
- 12.3.5 PolyPeptide Recent Developments
- 12.4 AmbioPharm
- 12.4.1 AmbioPharm Company Information
- 12.4.2 AmbioPharm Business Overview
- 12.4.3 AmbioPharm Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.4.4 AmbioPharm Peptide Synthesis CDMO Services Product Portfolio
- 12.4.5 AmbioPharm Recent Developments
- 12.5 Genscript
- 12.5.1 Genscript Company Information
- 12.5.2 Genscript Business Overview
- 12.5.3 Genscript Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.5.4 Genscript Peptide Synthesis CDMO Services Product Portfolio
- 12.5.5 Genscript Recent Developments
- 12.6 Thermo Fisher
- 12.6.1 Thermo Fisher Company Information
- 12.6.2 Thermo Fisher Business Overview
- 12.6.3 Thermo Fisher Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.6.4 Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio
- 12.6.5 Thermo Fisher Recent Developments
- 12.7 USV Peptides
- 12.7.1 USV Peptides Company Information
- 12.7.2 USV Peptides Business Overview
- 12.7.3 USV Peptides Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.7.4 USV Peptides Peptide Synthesis CDMO Services Product Portfolio
- 12.7.5 USV Peptides Recent Developments
- 12.8 Bio Basic
- 12.8.1 Bio Basic Company Information
- 12.8.2 Bio Basic Business Overview
- 12.8.3 Bio Basic Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.8.4 Bio Basic Peptide Synthesis CDMO Services Product Portfolio
- 12.8.5 Bio Basic Recent Developments
- 12.9 ScinoPharm
- 12.9.1 ScinoPharm Company Information
- 12.9.2 ScinoPharm Business Overview
- 12.9.3 ScinoPharm Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.9.4 ScinoPharm Peptide Synthesis CDMO Services Product Portfolio
- 12.9.5 ScinoPharm Recent Developments
- 12.10 JPT
- 12.10.1 JPT Company Information
- 12.10.2 JPT Business Overview
- 12.10.3 JPT Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.10.4 JPT Peptide Synthesis CDMO Services Product Portfolio
- 12.10.5 JPT Recent Developments
- 12.11 CBL
- 12.11.1 CBL Company Information
- 12.11.2 CBL Business Overview
- 12.11.3 CBL Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.11.4 CBL Peptide Synthesis CDMO Services Product Portfolio
- 12.11.5 CBL Recent Developments
- 12.12 Piramal Pharma
- 12.12.1 Piramal Pharma Company Information
- 12.12.2 Piramal Pharma Business Overview
- 12.12.3 Piramal Pharma Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.12.4 Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio
- 12.12.5 Piramal Pharma Recent Developments
- 12.13 CPC Scientific
- 12.13.1 CPC Scientific Company Information
- 12.13.2 CPC Scientific Business Overview
- 12.13.3 CPC Scientific Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.13.4 CPC Scientific Peptide Synthesis CDMO Services Product Portfolio
- 12.13.5 CPC Scientific Recent Developments
- 12.14 Creative Peptides
- 12.14.1 Creative Peptides Company Information
- 12.14.2 Creative Peptides Business Overview
- 12.14.3 Creative Peptides Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.14.4 Creative Peptides Peptide Synthesis CDMO Services Product Portfolio
- 12.14.5 Creative Peptides Recent Developments
- 12.15 Chinese Peptide Company
- 12.15.1 Chinese Peptide Company Company Information
- 12.15.2 Chinese Peptide Company Business Overview
- 12.15.3 Chinese Peptide Company Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.15.4 Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio
- 12.15.5 Chinese Peptide Company Recent Developments
- 12.16 ChengDu ShengNuo Biotec
- 12.16.1 ChengDu ShengNuo Biotec Company Information
- 12.16.2 ChengDu ShengNuo Biotec Business Overview
- 12.16.3 ChengDu ShengNuo Biotec Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.16.4 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio
- 12.16.5 ChengDu ShengNuo Biotec Recent Developments
- 12.17 AppTec Co., Ltd.
- 12.17.1 AppTec Co., Ltd. Company Information
- 12.17.2 AppTec Co., Ltd. Business Overview
- 12.17.3 AppTec Co., Ltd. Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.17.4 AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio
- 12.17.5 AppTec Co., Ltd. Recent Developments
- 12.18 GL Biochem
- 12.18.1 GL Biochem Company Information
- 12.18.2 GL Biochem Business Overview
- 12.18.3 GL Biochem Revenue in Peptide Synthesis CDMO Services Business (2021-2026)
- 12.18.4 GL Biochem Peptide Synthesis CDMO Services Product Portfolio
- 12.18.5 GL Biochem Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst